Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia:: an open, uncontrolled pilot study
Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia:: an open, uncontrolled pilot study
复制标题
DOI:
10.1016/j.fertnstert.2003.05.009
复制
发表时间:
2004-01-01
影响因子:
6.7
通讯作者:
Littarru, G
中科院分区:
文献类型:
--
作者:
Balercia, G;Mosca, F;Littarru, G
Objective: To clarify a potential therapeutic role of coenzyme Q(10) (CoQ(10)) in infertile men with idiopathic asthenozoospermia.Design: Open, uncontrolled pilot study.Patient(s): Infertile men with idiopathic asthenozoospermia.Intervention(s): CoQ(10) was administered orally; semen samples were collected at baseline and after 6 months of therapy.Main Outcome Measure(s): Semen kinetic parameters, including computer-assisted sperm data and CoQ(10) and phosphatidycholine levels.Result(s): CoQ(10) levels increased significantly in seminal plasma and in sperm cells after treatment. Phosphatidylcholine levels also increased. A significant increase was also found in sperm cell motility as confirmed by computer-assisted analysis. A positive dependence (using the Cramer's index of association) was evident among the relative variations, baseline and after treatment, of seminal plasma or intracellular CoQ(10) content and computer-determined kinetic parameters.Conclusion(s): The exogenous administration of CoQ(10) may play a positive role in the treatment of asthenozoospermia. This is probably the result of its role in mitochondrial bioenergetics and its antioxidant properties.